Hexagon Capital Partners LLC Grows Holdings in CVS Health Corporation (NYSE:CVS)

Hexagon Capital Partners LLC boosted its stake in CVS Health Corporation (NYSE:CVS) by 10.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,353 shares of the pharmacy operator’s stock after acquiring an additional 674 shares during the period. Hexagon Capital Partners LLC’s holdings in CVS Health were worth $498,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in CVS. Hopwood Financial Services Inc. bought a new position in shares of CVS Health during the fourth quarter worth about $29,000. McIlrath & Eck LLC lifted its holdings in CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 174 shares during the last quarter. Park Square Financial Group LLC acquired a new position in shares of CVS Health in the 4th quarter worth approximately $43,000. PARK CIRCLE Co increased its holdings in shares of CVS Health by 42.9% in the 4th quarter. PARK CIRCLE Co now owns 1,000 shares of the pharmacy operator’s stock valued at $45,000 after acquiring an additional 300 shares during the last quarter. Finally, Strategic Investment Solutions Inc. IL raised its position in shares of CVS Health by 77.2% during the 4th quarter. Strategic Investment Solutions Inc. IL now owns 1,024 shares of the pharmacy operator’s stock valued at $46,000 after acquiring an additional 446 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Guy P. Sansone bought 1,570 shares of the business’s stock in a transaction that occurred on Thursday, June 5th. The stock was acquired at an average cost of $63.70 per share, with a total value of $100,009.00. Following the completion of the purchase, the director directly owned 12,007 shares in the company, valued at approximately $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. Company insiders own 1.22% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on CVS shares. Mizuho boosted their target price on shares of CVS Health from $70.00 to $76.00 and gave the company an “outperform” rating in a research note on Wednesday, April 9th. Robert W. Baird boosted their price objective on shares of CVS Health from $51.00 to $71.00 and gave the company a “neutral” rating in a research report on Tuesday, April 15th. Cowen restated a “buy” rating on shares of CVS Health in a research note on Monday, May 5th. Truist Financial increased their price target on CVS Health from $82.00 to $84.00 and gave the stock a “buy” rating in a research report on Monday, May 12th. Finally, Wall Street Zen upgraded CVS Health from a “hold” rating to a “buy” rating in a research report on Friday, May 9th. Two equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $75.06.

CVS Health Trading Up 1.2%

CVS Health stock opened at $67.38 on Friday. The firm has a 50 day simple moving average of $65.11 and a 200-day simple moving average of $61.58. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.82 and a quick ratio of 0.63. The stock has a market capitalization of $85.23 billion, a PE ratio of 16.08, a price-to-earnings-growth ratio of 0.97 and a beta of 0.57. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $72.51.

CVS Health (NYSE:CVS) last released its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping analysts’ consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The firm had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. During the same period in the prior year, the firm posted $1.31 earnings per share. The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. As a group, equities research analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.